Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06280300 · ClinicalTrials.gov registry record · NA
Multi-disciplinary Care for Brain Metastases
A NA study of Brain Metastases, Adult, sponsored by University of Vermont Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06280300 is a NA study of Brain Metastases, Adult that is actively recruiting participants, run by University of Vermont Medical Center. The registered enrollment target is 40 participants, below the 94-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06280300, a NA study of Brain Metastases, Adult, is actively recruiting participants, sponsored by University of Vermont Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Conditions Studied
Interventions
- OTHER health services intervention
Study Locations (1)
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06280300
The ClinicalTrials.gov registry entry for NCT06280300 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 94-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (57% lower). The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Metastases, Adult appearing as the primary indexed condition, and to 1 intervention - of which health services intervention is the first listed.
NCT06280300 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT06280300 about?
NCT06280300 is a clinical study titled "Multi-disciplinary Care for Brain Metastases". This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
What is the current status of trial NCT06280300?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-11-16. Estimated completion is 2027-07-01.
What conditions does trial NCT06280300 study?
This clinical trial studies the following conditions: Brain Metastases, Adult.
What interventions are being tested in trial NCT06280300?
The interventions under investigation include: health services intervention (OTHER).
Who is sponsoring clinical trial NCT06280300?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06280300 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases
ACTIVE NOT RECRUITING · NA
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
RECRUITING · Phase 1
-
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
RECRUITING · Phase 2
-
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.